Please complete the CAPTCHA to continue
@bioquadrant.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Jo Van Betsbrugge, Phd is listed as President CMC-Rx Consultancy | Drug Development Leader - Small Molecules & Peptides at CMC-Rx Consultancy, based in Greater Montreal Metropolitan Area, Canada, Canada. AeroLeads shows a work email signal at bioquadrant.com and a matched LinkedIn profile for Jo Van Betsbrugge, Phd.
Jo Van Betsbrugge, Phd previously worked as President, Full-time Pharmaceutical Development Consultant at Cmc-Rx Consultancy and Senior Consultant Chemistry, Manufacturing & Controls at Kinexum Services Llc. Jo Van Betsbrugge, Phd holds Ph.D from Vrije Universiteit Brussel.
This section adds company-level context without repeating Jo Van Betsbrugge, Phd's masked contact details.
AeroLeads found 1 current-domain work email signal for Jo Van Betsbrugge, Phd. Compare company email patterns before reaching out.
Montreal-area based Drug Development professional, Life Sciences entrepreneur, biopharmaceutical scientist, synthetic organic chemist, co-inventor of Eli Lilly/Amphastar nasal glucagon (BAQSIMI). Specialty: Management of CMC (Chemistry, Manufacturing & Controls), small molecule drugs, peptides, peptide mimetic, intranasal drug delivery, solid oral and injectable dosage forms, synthetic organic chemistry, biotech, drug discovery & development. I cover and manage all areas of CMC development, from pre-clinical development of small molecules and peptides, to formulation development, clinical manufacturing, and scale-up.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Greater Montreal Metropolitan Area
With 20+ years of hands-on experience in small molecule CMC development, I assist drug developers with the management of the Chemistry, Manufacturing, and Controls aspects of drug development, from pre-clinical development of small molecules and peptides, to formulation development, clinical manufacturing, and scale-up. Clients typically use me as their.
Washington DC-area
Providing CMC-related assistance to Kinexum's national and international clients: CMC gap analysis, management of drug substance and drug product development programs across multiple therapeutic areas.Co-authoring of Pre-IND meeting requests, and INDs (Module 3).Technical due diligence on late-stage drug development programs.
Montreal, Quebec, Canada
Leading Find Therapeutics' drug substance and drug product CMC development program; development and manufacture of clinical drug substance supply, development and manufacture of clinical drug product supply. Authoring of regulatory submissions (Module 3).
Management of TIXiMED's drug substance and drug product development and clinical manufacturing programs. Authoring of regulatory submission.
London, England, United Kingdom
Leading Kaerus' drug product development and manufacturing program. Authoring of regulatory submission (CMC).
Greater Montreal Metropolitan Area
Greater Quebec City Metropolitan Area
Maresins Pharma/SPM Therapeutics develops disruptive treatments for detrimental inflammation and pain by harnessing the natural power of maresin compounds.I've been leading the company's drug substance and drug product development activities since July 2019.
Skokie, Illinois, United States
Reporting to the VP Technical Operations and CEO, I provided CMC oversight to one of Levo’s drug substance and drug product development programs. Levo Therapeutics was acquired by Acadia Pharmaceuticals (San Diego) in 2022.
Greater Montreal Metropolitan Area
Member of Ovensa's Scientfic Advisory Board
Montreal, Canada Area
Helping Innovative Firms Grow in Canada through Funding and Advice. Specialty: bio+pharma.Industrial Technology Advisor (biotech/pharma) at the National Research Council's Industrial Research Assistance Program (IRAP). Provided technical and business assessments, strategic advisory services and funding to High Potential Firms. Expert on non-dilutive.
Laval, QC, Canada
BioQuadrant Inc: a chemistry-based Contract Development & Manufacturing Organization (CDMO) catering to very specific needs of clients in the biopharma industry. 2006 Graduate CQIB Life Sci incubator, Laval, Canada. As BioQuadrant's CSO, I led the successful execution of 80+ milestone-driven projects in the Life Sciences field.Examples:2009-2013.
Montreal, Canada Area
Key tasks: strategic scientific planning (budgets, protocol development,...) of Insymbiosis' pre-clinical chemistry programs; project management of all chemistry-related projects; preparation of R&D proposals for international clients; analogue syntheses and scale-up of experimental drugs; consultation on CMC-related issues; development of a comprehensive.
Development and scale-up of a novel synthesis route for a thrombin inhibitor.
Solid-supported synthesis of azasugar peptide mimetics. Laboratory for Organic Chemistry; Director: Prof. Dr. William D. Lubell
Quick answers generated from the profile data available on this page.
Jo Van Betsbrugge, Phd works for CMC-Rx Consultancy.
Jo Van Betsbrugge, Phd is listed as President CMC-Rx Consultancy | Drug Development Leader - Small Molecules & Peptides at CMC-Rx Consultancy.
AeroLeads has found 1 work email signal at @bioquadrant.com for Jo Van Betsbrugge, Phd at CMC-Rx Consultancy.
Jo Van Betsbrugge, Phd is based in Greater Montreal Metropolitan Area, Canada, Canada while working with CMC-Rx Consultancy.
Jo Van Betsbrugge, Phd has worked for Cmc-Rx Consultancy, Kinexum Services Llc, Find Therapeutics, Tiximed, and Kaerus Bioscience Ltd..
You can use AeroLeads to view verified contact signals for Jo Van Betsbrugge, Phd at CMC-Rx Consultancy, including work email, phone, and LinkedIn data when available.
Jo Van Betsbrugge, Phd holds Ph.D from Vrije Universiteit Brussel.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts